DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 45 · June 2012 DOI: 10.1055/s-002-23307

Original Paper

  • 127
    Haueis, P.; Russmann, S.; Zorina, O. I.; Grohmann, R.; Kullak-Ublick, G. A.; Jaquenoud Sirot, E.; Russmann, H.:

    Coprescription of Levodopa with Antipsychotics in a Population of 84 596 Psychiatric Inpatients from 1994 to 2008

  • 133
    Shinfuku, M.; Uchida, H.; Tsutsumi, C.; Suzuki, T.; Watanabe, K.; Kimura, Y.; Tsutsumi, Y.; Ishii, K.; Imasaka, Y.; Mimura, M.; Kapur, S.:

    How Psychotropic Polypharmacy in Schizophrenia Begins: A Longitudinal Perspective

  • 138
    Frasch, K.; Weiser, P.; Becker, T.; Längle, G.; Steinert, T.; Niederreiner, C.; Pfiffner, C.; Jäger, S.; Bayer, W.; Eschweiler, G. W.; Kilian, R.:

    Psychotropic Drug Treatment, Clinical Characteristics and Cognitive Processing Speed in Patients with Schizophrenia: Results from the ELAN Study

  • 146
  • 152
  • 156
    Huber, C. G.; Hoppe, A.; Agorastos, A.; Andresen, B.; Naber, D.; Schroeder, K.:

    Are Ratings on the Positive and Negative Syndrome Scale for Schizophrenia Biased by Personality Traits?

  • Letter

  • 162
  • 163
  • 164